As on Thursday, Immuneering Corp (NASDAQ: IMRX) started slowly as it slid -5.86% to $2.09, before settling in for the price of $2.22 at the close. Taking a more long-term approach, IMRX posted a 52-week range of $1.00-$8.89.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -43.59%. Meanwhile, its Annual Earning per share during the time was -57.97%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -0.30%. This publicly-traded company’s shares outstanding now amounts to $29.27 million, simultaneously with a float of $21.00 million. The organization now has a market capitalization sitting at $61.97 million. At the time of writing, stock’s 50-day Moving Average stood at $1.81, while the 200-day Moving Average is $2.80.
Immuneering Corp (IMRX) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Immuneering Corp’s current insider ownership accounts for 29.18%, in contrast to 32.37% institutional ownership. According to the most recent insider trade that took place on Apr 01 ’24, this organization’s 10% Owner sold 400,000 shares at the rate of 2.90, making the entire transaction reach 1,160,181 in total value, affecting insider ownership by 2,895,273. Preceding that transaction, on Mar 22 ’24, Company’s Director bought 2,900 for 2.55, making the whole transaction’s value amount to 7,385. This particular insider is now the holder of 2,900 in total.
Immuneering Corp (IMRX) Earnings and Revenue Records
Immuneering Corp’s EPS decrease for this current 12-month fiscal period is -0.30% and is forecasted to reach -1.64 in the upcoming year.
Immuneering Corp (NASDAQ: IMRX) Trading Performance Indicators
Let’s observe the current performance indicators for Immuneering Corp (IMRX). It’s Quick Ratio in the last reported quarter now stands at 9.39. The Stock has managed to achieve an average true range (ATR) of 0.32.
In the same vein, IMRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.91, a figure that is expected to reach -0.55 in the next quarter, and analysts are predicting that it will be -1.64 at the market close of one year from today.
Technical Analysis of Immuneering Corp (IMRX)
Through scrutinizing the latest numbers posted by the [Immuneering Corp, IMRX], it can be observed that its last 5-days Average volume of 5.97 million was better the volume of 2.46 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 39.46% While, its Average True Range was 0.30.
Raw Stochastic average of Immuneering Corp (IMRX) in the period of the previous 100 days is set at 38.52%, which indicates a major rise in contrast to 23.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 96.69% that was lower than 135.24% volatility it exhibited in the past 100-days period.
